Alligator Bioscience Signs Agreement To Sell Mitazalimab to Biossil

LUND, SE / ACCESS Newswire / October 31, 2026 / Alligator Bioscience (STO:ATORX)(Nasdaq Stockholm:ATORX), a biotechnology company whose principal asset is a financial interest in the HER2-targeting antibody program HLX22, today announced that it has …